-
May 30, 2024
How Would an Expert Manage His Own Acute Myelogenous Leukemia: an Update
With: Adam Asch, MDWhen facing a frightening new cancer diagnosis, some people ask their doctors, “What would you do if you were me?” Previously, our Curious Dr. George asked leukemia expert Adam Asch, MD, how he would handle his own hypothetical case of acute myelogenous leukemia (AML). Now, Dr. Asch provides an updated answer, highlighting the new option of clinical trials offering novel targeted therapies for some… Read more »
-
October 24, 2023
How Would an Expert Manage His Own Acute Myelogenous Leukemia?
With: Adam Asch, MDWhen facing a frightening new cancer diagnosis, some people ask their doctors, “What would you do if you were me?” Here, our Curious Dr. George asks leukemia expert Adam Asch, MD, how he would handle his own case of acute myelogenous leukemia. Dr. Asch is Professor of Medicine and Nancy Johnson Records Chair of Oncology at the University of Oklahoma College of Medicine. Curious… Read more »
-
July 13, 2022
Chronic Myelomonocytic Leukemia: 2022 Update on Diagnosis, Risk Stratification, and Management Bookmark
George Lundberg, MDWritten for oncology healthcare professionals, this article from the American Journal of Hematology covers the best new therapies for chronic myelomonocytic leukemia in 2022.
.
SEE ALL
Dave
Patient with metastatic neuroendocrine tumor of the pancreas
-
October 11, 2022
Demystifying Cancer Biomarkers: Webinar Recap
Sarah StanleyIf you have just been diagnosed with cancer, or are facing recurrence, progression, or a change in treatment, you may feel bombarded with new information and advice. At some point, a clinician or even a well-meaning friend may urge you to have “biomarker testing” done. This phrase can be especially confusing when dealing with the stress of trying to understand a new diagnosis, a… Read more »
-
March 22, 2022
Immunotherapy to Treat Cancer Bookmark
George Lundberg, MDImmunotherapy uses biological substances, such as your own immune system, to attack cancer cells. Learn more about immunotherapy from the National Cancer Institute.
.
SEE ALL
Some of the most promising new treatments for advanced leukemia are currently being tested in patients enrolled in clinical trials. We help you stay up to date on the latest results from these studies.
-
November 12, 2019
ADMIRAL: Gilteritinib vs Chemotherapy in Relapsed or Refractory FLT3-Mutated AML Bookmark
George Lundberg, MDArticle from The ASCO Post curated by Editor in Chief George Lundberg, MD, who notes:
A clinical trial showed substantial benefits of progression-free survival and overall survival for patients with a particular form of acute myeloid leukemia when treated by gilteritinib versus chemotherapy. However, the disease was still fatal.
Go to full article published by The ASCO Post.
If you’re wondering whether this story applies to your own cancer case or a loved one’s, we invite you to get support from Cancer Commons.
SEE ALL
Gavin Gordon, PhD
Molecular Pathologist
Cancer affects many aspects of life, whether you’re newly diagnosed, in the midst of treatment, or in follow-up care. Learn about ways to maintain quality of life, such as palliative care and managing side effects.
-
October 14, 2019
Pediatric Palliative Care: A Specialty Comes of Age
For a child with cancer, palliative care can provide much-needed relief from stress and symptoms—for the patient and their family alike. Palliative care is given alongside cancer treatment, and is not synonymous with “end-of-life” care. In fact, anyone with a serious illness can benefit from palliative care, no matter their long-term outlook. Because of its importance for children with cancer, we are honored to… Read more »
-
August 11, 2021
Anxiety Before Each Chemotherapy Treatment Bookmark
Lola Rahib, PhDArticle from Let’s Win! Pancreatic Cancer: Pancreatic cancer patients share their experiences with pre-chemo anxiety and their personal strategies for overcoming it.
.
-
February 11, 2020
‘Impressed With Impact’ of Ketamine in Cancer Palliative Care Bookmark
George Lundberg, MDArticle from Medscape curated by Editor in Chief George Lundberg, MD, who notes:
Depression is, for obvious reasons, common in patients with advanced cancer. The old, inexpensive drug ketamine—already approved for medical use by the U.S. Food and Drug Administration (FDA)—seems rapidly effective, according to small studies.
Go to full article published by Medscape.
If you’re wondering whether this story applies to your own cancer case or a loved one’s, we invite you to get support from Cancer Commons.
SEE ALL
Learn more about what’s new in advanced cancer research and treatment, including screening and statistics, using artificial intelligence to improve treatment, and other new horizons in cancer care.
-
July 11, 2024
The Personalized Power of the “N-of-1” Approach
With:Randomized, controlled clinical trials with a large N—number of participants—are the recognized “gold standard” of evidence-based medicine. Even so, the results of large-N trials can only reveal population averages, and are not predictive of any individual’s response to a given treatment. On the other hand, one can consider every patient with cancer as the sole participant in their own clinical trial with an Nof1, even if the trial is not… Read more »
-
November 10, 2022
A Powerful Knowledge Base for Precision Oncology
With:Genetic mutations found in a tumor can be important clues to the patient’s best treatment options. Memorial Sloan Kettering Cancer Center (MSK) in New York has developed a product called OncoKB™, which enables anyone to access and navigate key clinical information about the various genetic abnormalities that may be found in tumors. Here, Curious Dr. George asks MSK Lead Software Engineer Hongxin Zhang about… Read more »
-
June 2, 2022
Harnessing Each Patient’s Data to Help Many More
With: Kaumudi Bhawe, PhDAt Cancer Commons, we don’t just help people navigate cancer treatment; we learn from everyone we help. Here, our Curious Dr. George asks Cancer Commons Clinical Scientist Kaumudi Bhawe, PhD, to share how new knowledge can be captured from every patient to help many more. Curious Dr. George: Cancer Commons has accumulated in-depth data on many hundreds of patients with various cancers. Because of the… Read more »
SEE ALL
The coronavirus pandemic presents unprecedented challenges to cancer patients. We can help you understand how COVID-19 might impact your treatment and other aspects of your cancer care.
-
February 20, 2021
COVID-19 Vaccination: The VOICE for Patients with Cancer Bookmark
George Lundberg, MDThis piece from the scientific journal Nature Medicine describes a new clinical trial studying vaccination against COVID-19 specifically in patients with cancer.
.
-
February 20, 2021
Patients with Cancer Less Likely to Enroll in Clinical Trials Due to COVID-19 Bookmark
George Lundberg, MDFewer patients with cancer may be willing to enter a clinical trial. This Cancer Network article explains why and offers solutions.
.
SEE ALL